JP2002284691A - Composition for oral cavity taken before meal - Google Patents
Composition for oral cavity taken before mealInfo
- Publication number
- JP2002284691A JP2002284691A JP2001092208A JP2001092208A JP2002284691A JP 2002284691 A JP2002284691 A JP 2002284691A JP 2001092208 A JP2001092208 A JP 2001092208A JP 2001092208 A JP2001092208 A JP 2001092208A JP 2002284691 A JP2002284691 A JP 2002284691A
- Authority
- JP
- Japan
- Prior art keywords
- meal
- composition
- oral
- oral composition
- saliva
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 66
- 235000012054 meals Nutrition 0.000 title claims abstract description 44
- 210000000214 mouth Anatomy 0.000 title abstract description 10
- -1 sucrose fatty acid ester Chemical class 0.000 claims abstract description 22
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 15
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 11
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 9
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000004359 castor oil Substances 0.000 claims abstract description 9
- 235000019438 castor oil Nutrition 0.000 claims abstract description 9
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims abstract description 9
- 229940041616 menthol Drugs 0.000 claims abstract description 9
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 9
- 229930006000 Sucrose Natural products 0.000 claims abstract description 8
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims abstract description 8
- 235000019477 peppermint oil Nutrition 0.000 claims abstract description 8
- 239000005720 sucrose Substances 0.000 claims abstract description 8
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 7
- 239000000194 fatty acid Substances 0.000 claims abstract description 7
- 229930195729 fatty acid Natural products 0.000 claims abstract description 7
- 239000001683 mentha spicata herb oil Substances 0.000 claims abstract description 7
- 235000019721 spearmint oil Nutrition 0.000 claims abstract description 7
- 239000005973 Carvone Substances 0.000 claims abstract description 6
- 150000005215 alkyl ethers Chemical class 0.000 claims abstract description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims 1
- 229960004889 salicylic acid Drugs 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 30
- 210000003296 saliva Anatomy 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 14
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 abstract description 12
- 239000003242 anti bacterial agent Substances 0.000 abstract description 8
- 230000001603 reducing effect Effects 0.000 abstract description 7
- 229960001047 methyl salicylate Drugs 0.000 abstract description 6
- 239000004615 ingredient Substances 0.000 abstract description 5
- 230000014860 sensory perception of taste Effects 0.000 abstract 1
- 235000019640 taste Nutrition 0.000 description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 8
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 8
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 8
- 239000000606 toothpaste Substances 0.000 description 8
- 229940034610 toothpaste Drugs 0.000 description 8
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 208000025157 Oral disease Diseases 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 230000001013 cariogenic effect Effects 0.000 description 6
- 208000030194 mouth disease Diseases 0.000 description 6
- 239000002324 mouth wash Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 208000002925 dental caries Diseases 0.000 description 5
- 239000000551 dentifrice Substances 0.000 description 5
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 5
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 4
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical compound C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 description 4
- 150000008051 alkyl sulfates Chemical class 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 229940051866 mouthwash Drugs 0.000 description 4
- 229940085605 saccharin sodium Drugs 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 239000003082 abrasive agent Substances 0.000 description 3
- 239000004599 antimicrobial Substances 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 3
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 3
- 235000010413 sodium alginate Nutrition 0.000 description 3
- 239000000661 sodium alginate Substances 0.000 description 3
- 229940005550 sodium alginate Drugs 0.000 description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 3
- 235000010234 sodium benzoate Nutrition 0.000 description 3
- 239000004299 sodium benzoate Substances 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- FCEXWTOTHXCQCQ-UHFFFAOYSA-N Ethoxydihydrosanguinarine Natural products C12=CC=C3OCOC3=C2C(OCC)N(C)C(C2=C3)=C1C=CC2=CC1=C3OCO1 FCEXWTOTHXCQCQ-UHFFFAOYSA-N 0.000 description 2
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- 229940011037 anethole Drugs 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229940067596 butylparaben Drugs 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical class C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 235000015205 orange juice Nutrition 0.000 description 2
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- 229940084560 sanguinarine Drugs 0.000 description 2
- YZRQUTZNTDAYPJ-UHFFFAOYSA-N sanguinarine pseudobase Natural products C1=C2OCOC2=CC2=C3N(C)C(O)C4=C(OCO5)C5=CC=C4C3=CC=C21 YZRQUTZNTDAYPJ-UHFFFAOYSA-N 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 229950005425 sodium myristyl sulfate Drugs 0.000 description 2
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 2
- 239000001074 1-methoxy-4-[(E)-prop-1-enyl]benzene Substances 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- YJFSKTXFJSLNKF-UHFFFAOYSA-N 3-hexadecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCC1=CC=C[NH+]=C1 YJFSKTXFJSLNKF-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- AXCXHFKZHDEKTP-NSCUHMNNSA-N 4-methoxycinnamaldehyde Chemical compound COC1=CC=C(\C=C\C=O)C=C1 AXCXHFKZHDEKTP-NSCUHMNNSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 239000005749 Copper compound Substances 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 101100321669 Fagopyrum esculentum FA02 gene Proteins 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 description 1
- 206010035669 Pneumonia aspiration Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- ZPVGIKNDGJGLCO-VGAMQAOUSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZPVGIKNDGJGLCO-VGAMQAOUSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 201000009807 aspiration pneumonia Diseases 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- ROPDWRCJTIRLTR-UHFFFAOYSA-L calcium metaphosphate Chemical compound [Ca+2].[O-]P(=O)=O.[O-]P(=O)=O ROPDWRCJTIRLTR-UHFFFAOYSA-L 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- 229940077441 fluorapatite Drugs 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical group COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 229910000392 octacalcium phosphate Inorganic materials 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229940068984 polyvinyl alcohol Drugs 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 229920003002 synthetic resin Chemical group 0.000 description 1
- 239000000057 synthetic resin Chemical group 0.000 description 1
- YIGWVOWKHUSYER-UHFFFAOYSA-F tetracalcium;hydrogen phosphate;diphosphate Chemical group [Ca+2].[Ca+2].[Ca+2].[Ca+2].OP([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O YIGWVOWKHUSYER-UHFFFAOYSA-F 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、食前に適用するこ
とにより、食前の唾液中の口腔疾患原因細菌数を大幅に
減少させ、直後の食事の味覚に影響がなく、好ましくは
抗菌剤の薬効成分を配合した食後使用の口腔用組成物と
併用することによって唾液中の口腔疾患の原因細菌数を
低レベルで維持できる食前使用口腔用組成物に関する。BACKGROUND OF THE INVENTION The present invention, when applied before a meal, greatly reduces the number of bacteria causing oral diseases in saliva before a meal, does not affect the taste of the meal immediately after the meal, and preferably has the medicinal properties of an antibacterial agent. The present invention relates to a pre-meal oral composition which is capable of maintaining a low level of bacteria causing oral diseases in saliva at a low level when used in combination with a post-meal oral composition containing components.
【0002】[0002]
【従来の技術及び発明が解決しようとする課題】通常、
歯磨きは食後に行なうことが推奨されている。特に近年
では、口腔内の細菌数を長時間低レベルで維持する口腔
用組成物の検討が数多くなされている。しかし、口腔内
細菌数の多い人の場合、食後に口腔用組成物を適用する
だけでは、口腔内細菌数を低レベルに維持することが困
難で、口腔疾患を発症したり、感染させたりするリスク
が高いという問題点があった。BACKGROUND OF THE INVENTION Generally,
It is recommended that you brush your teeth after meals. Particularly in recent years, many studies have been made on oral compositions that maintain the bacterial count in the oral cavity at a low level for a long time. However, for people with a high oral bacterial count, simply applying the oral composition after a meal makes it difficult to maintain a low oral bacterial count, causing oral disease or causing infection There was a problem that the risk was high.
【0003】一方、口腔内細菌数の日間変動は食前にお
いて多くなり、特に朝食前においてその細菌数は最大と
なるが、食前に何も口腔用組成物を適用しないで食事を
することは、唾液中の多くの細菌を食事と共に飲食する
ことを意味し、近年、高レベルな唾液中の細菌数が、胃
炎や誤嚥性肺炎等の疾患リスクを高めると言われてい
る。[0003] On the other hand, the daily fluctuation of the number of bacteria in the oral cavity increases before a meal, and especially the number of bacteria reaches the maximum before breakfast. However, eating without applying any oral composition before a meal requires saliva. It means that many bacteria in the food are eaten and consumed with meals. In recent years, it is said that a high level of bacteria in saliva increases the risk of diseases such as gastritis and aspiration pneumonia.
【0004】口腔内細菌に対して効果のある口腔用組成
物はこれまでにも数多く提案されているが、その中でも
唾液中の細菌数を低減させる口腔用組成物としては、サ
ンギナリン抽出物の口内リンス組成物(特開平3−14
513号公報)、ハロゲン化ジフェニルエーテル配合の
口腔用組成物(特開平10−330230号公報)等が
知られている。[0004] Many oral compositions effective against oral bacteria have been proposed so far. Among them, oral compositions for reducing the number of bacteria in saliva include the oral extract of sanguinarine extract. Rinse composition (Japanese Unexamined Patent Application Publication No.
No. 513), and an oral composition containing a halogenated diphenyl ether (JP-A-10-330230).
【0005】しかし、以上のような抗菌剤配合口腔用組
成物では、経時後の口腔内細菌を低減させる高い効果を
有するものの、通常に使用される濃度では、使用直後の
細菌数を1/100以下にするのは困難であった。ま
た、抗菌剤は、配合濃度を高めることによって目的をク
リアできるが、抗菌剤配合の口腔用組成物を食前に使用
することについて、その直後の食事時に、飲食物と一緒
に多量の抗菌剤を飲みこむ可能性に嫌悪感を抱く生活者
が少なからず存在する問題点があった。[0005] However, although the above oral composition containing an antibacterial agent has a high effect of reducing oral bacteria after a lapse of time, the number of bacteria immediately after use is reduced by 1/100 at a concentration usually used. It was difficult to: In addition, the antimicrobial agent can clear the purpose by increasing the concentration, but about the use of the oral composition containing the antimicrobial agent before meals, at the time of the meal immediately after that, a large amount of antimicrobial agents with food and drink There is a problem that not a few consumers have an aversion to the possibility of swallowing.
【0006】一方、Jenkinsらは、ラウリル硫酸
ナトリウム等のアニオン界面活性剤が抗菌剤と同等以上
の使用直後の唾液中細菌に対して低減効果を有すること
を見出している(Jenkins et al,J.C
lin Periodontal,18(2),P14
0,1991)。On the other hand, Jenkins et al. Have found that an anionic surfactant such as sodium lauryl sulfate has a reducing effect on salivary bacteria immediately after use, which is at least equal to that of an antibacterial agent (Jenkins et al., J. Biol. C
lin Periodontal, 18 (2), P14
0, 1991).
【0007】ラウリル硫酸ナトリウム等のアニオン界面
活性剤は、歯磨成分としては公知であるが、特に使用
後、酸味の強い食べ物、代表的にはオレンジジュースを
飲むと、本来の味とは異なる、いわゆる「ジュース効
果」によって苦味が発現したり、「ほこりっぽさ」を感
じることがある。[0007] Anionic surfactants such as sodium lauryl sulfate are known as dentifrice components. However, especially after use, when drinking a food with a strong acidity, typically orange juice, the taste differs from the original taste. The "juice effect" may cause bitterness or a feeling of "dustiness".
【0008】アルキル硫酸塩等のアニオン界面活性剤配
合の組成物を使用することによって生じる「ジュース効
果」を解消する手段としては、各種の非イオン界面活性
剤(特開昭55−13250号、同55−92309
号、同55−92310号、同56−97215号、同
56−166112号、同58−118506号、同6
1−194012号公報)や特定のアニオン界面活性剤
(特開平2−256608号公報)、天然系糖タンパク
(特開昭61−36214号公報)等を用いることが知
られている。As means for eliminating the "juice effect" caused by using a composition containing an anionic surfactant such as an alkyl sulfate, various nonionic surfactants (JP-A-55-13250, JP-A-55-13250, and 55-92309
Nos. 55-92310, 56-97215, 56-166112, 58-118506, and 6
It is known to use a specific anionic surfactant (JP-A-2-256608), a natural glycoprotein (JP-A-61-36214), and the like.
【0009】しかし、上記のような組成物で、唾液中の
微生物数を低減させることに言及したものはなく、逆
に、従来提案されている非イオン界面活性剤配合組成物
では、「ジュース効果」を解消するだけでなく、アルキ
ル硫酸塩等のアニオン界面活性剤の唾液中に存在する口
腔疾患原因細菌数を低減する効果そのものも抑制してし
まう。[0009] However, there is no mention of reducing the number of microorganisms in saliva with the above-mentioned composition, and conversely, in the composition proposed with a nonionic surfactant conventionally proposed, the "juice effect" is not considered. In addition, the effect of reducing the number of bacteria that cause oral diseases in saliva by anionic surfactants such as alkyl sulfates is also suppressed.
【0010】更に、メントール、カルボン、ペパーミン
ト油、スペアミント油、サリチル酸メチル等の清涼感の
強い香料を通常配合されるレベルで配合すると、その清
涼感の持続により、食事の味に影響する問題があること
が判明した。Further, when a refreshing flavor such as menthol, carvone, peppermint oil, spearmint oil, methyl salicylate or the like is blended at a usual level, there is a problem that the refreshing sensation is sustained and the taste of the meal is affected. It has been found.
【0011】なお、食後使用の口腔用組成物と併用する
食前使用口腔用組成物について、これまで提案されたも
のはない。[0011] There has been no proposal for a pre-meal oral composition to be used in combination with a post-meal oral composition.
【0012】[0012]
【課題を解決するための手段及び発明の実施の形態】以
上のような点から、本発明者は、唾液中のう蝕原因細菌
数をう蝕の発症を大幅に減少できる1/100以下に減
少させ、かつジュース効果を生じさせない食前使用口腔
用組成物につき鋭意研究を進めたところ、ラウリル硫酸
ナトリウム、ミリスチル硫酸ナトリウム等のアルキル硫
酸塩やアシルサルコシン塩等のアニオン界面活性剤を組
成物全体の0.1〜3%(質量百分率、以下同じ)配合
し、ショ糖脂肪酸エステル、ポリオキシエチレン(PO
E)硬化ヒマシ油、ポリオキシエチレンアルキルエーテ
ルから選ばれる非イオン界面活性剤の1種又は2種以上
をアニオン界面活性剤の1/5〜2/3配合することに
よって、唾液中のう蝕原因細菌数を1/100以下に減
少させ、かつジュース効果が生じないことを知見した。
さらに、清涼感のために通常、口腔用組成物の香料の主
成分として配合されているメントール、カルボン、ペパ
ーミント油、スペアミント油、サリチル酸メチルの合計
配合量を組成物全体の0.5%以下に減じることによっ
て、清涼感の持続が食事の味へ影響のないことを知見
し、本発明をなすに至った。SUMMARY OF THE INVENTION In view of the above, the present inventor has found that the number of caries-causing bacteria in saliva is reduced to 1/100 or less at which the onset of caries can be significantly reduced. The inventors of the present invention have conducted intensive studies on compositions for oral use before meals that reduce the amount of juice and do not produce a juice effect. 0.1-3% (mass percentage, the same applies hereinafter), sucrose fatty acid ester, polyoxyethylene (PO
E) Cause of dental caries in saliva by mixing one or more nonionic surfactants selected from hydrogenated castor oil and polyoxyethylene alkyl ether with 1/5 to 2/3 of anionic surfactants It was found that the number of bacteria was reduced to 1/100 or less, and that no juice effect occurred.
Further, the total amount of menthol, carvone, peppermint oil, spearmint oil, and methyl salicylate, which are usually blended as a main component of the flavor of the oral composition for a refreshing feeling, is reduced to 0.5% or less of the whole composition. By reducing the amount, it was found that the continuation of the refreshing sensation did not affect the taste of meal, and the present invention was achieved.
【0013】以下、本発明につき更に詳しく説明する。
本発明の食前使用口腔用組成物は、食後使用の口腔用組
成物と併用する口腔用組成物であって、アニオン界面活
性剤を0.1〜3%含有すると共に、ショ糖脂肪酸エス
テル、ポリオキシエチレン硬化ヒマシ油及びポリオキシ
エチレンアルキルエーテルから選ばれる非イオン界面活
性剤を上記アニオン界面活性剤量の1/5〜2/3含有
し、かつメントール、カルボン、ペパーミント油、スペ
アミント油及びサリチル酸メチルの配合量の合計が0.
5%以下であることを特徴とする。Hereinafter, the present invention will be described in more detail.
The oral composition for pre-meal use of the present invention is an oral composition used in combination with an oral composition for post-meal use, which contains 0.1 to 3% of an anionic surfactant, and contains sucrose fatty acid ester and poly A nonionic surfactant selected from oxyethylene hydrogenated castor oil and polyoxyethylene alkyl ether is contained in an amount of 1/5 to 2/3 of the amount of the above anionic surfactant, and menthol, carvone, peppermint oil, spearmint oil and methyl salicylate are contained. Is 0.
It is not more than 5%.
【0014】ここで、アニオン界面活性剤としては、特
に炭素数8〜18のアルキル硫酸塩、炭素数8〜18の
アシルサルコシン塩が好ましく、具体的にはラウリル硫
酸ナトリウム、ミリスチル硫酸ナトリウム、ラウロイル
サルコシンナトリウム等が用いられる。As the anionic surfactant, alkyl sulfates having 8 to 18 carbon atoms and acyl sarcosine salts having 8 to 18 carbon atoms are particularly preferable. Specifically, sodium lauryl sulfate, sodium myristyl sulfate and lauroyl sarcosine are preferred. sodium and the like are used.
【0015】ラウリル硫酸ナトリウム、ミリスチル硫酸
ナトリウム等のアルキル硫酸塩やラウロイルサルコシン
塩等のアニオン界面活性剤は、上述したように0.1〜
3%、より好ましくは0.5〜2%の配合量で使用され
る。0.1%未満では、唾液中のう蝕原因細菌数をう蝕
の発症を大幅に減少できる1/100以下に減じること
ができず、3%を超える量を配合すると「ジュース効
果」が出現する場合がある。また、上記非イオン界面活
性剤の1種又は2種以上をアニオン界面活性剤の1/5
〜2/3の割合で配合するが、1/5未満であれば、
「ジュース効果」が生じ、2/3を超える量を配合する
と、う蝕原因細菌数を1/100以下に減じることがで
きない場合が生じる。Alkyl sulfates, such as sodium lauryl sulfate and sodium myristyl sulfate, and anionic surfactants, such as lauroyl sarcosine salt, are used in an amount of 0.1 to 0.1 as described above.
It is used in an amount of 3%, more preferably 0.5-2%. If the amount is less than 0.1%, the number of caries-causing bacteria in saliva cannot be reduced to 1/100 or less, which can significantly reduce the occurrence of dental caries. When the amount exceeds 3%, the "juice effect" appears. May be. In addition, one or more of the above nonionic surfactants are 1 / of the anionic surfactant.
Although it is blended at a ratio of ~ 2/3, if less than 1/5,
When the "juice effect" occurs and the amount is more than 2/3, the number of carious bacteria may not be reduced to 1/100 or less.
【0016】なお、ショ糖脂肪酸エステルは、ショ糖と
炭素数12〜29である脂肪酸の1種又は2種以上の脂
肪酸混合物とのモノ、ジ又はそれ以上のエステルであ
る。ショ糖とエステル化する脂肪酸は、特に炭素数12
〜18の飽和脂肪酸が好適である。また、エステルの種
類のうち、モノエステルの割合は0〜80%であり、特
に30〜80%のものが好適である。ポリオキシエチレ
ン硬化ヒマシ油は、硬化ヒマシ油に酸化エチレンを付加
したもので、通常、5〜80モルの酸化エチレンが付加
されている。この中で特に20〜60モルの酸化エチレ
ンを付加しているものが好適である。ポリオキシエチレ
ンアルキルエーテルは、下記式(1)で示されるものが
好適である。The sucrose fatty acid ester is a mono-, di- or higher ester of sucrose and a mixture of one or more fatty acids having 12 to 29 carbon atoms. Fatty acids which are esterified with sucrose have particularly 12 carbon atoms.
-18 saturated fatty acids are preferred. Further, among the types of esters, the proportion of monoester is 0 to 80%, and particularly preferably 30 to 80%. Polyoxyethylene hydrogenated castor oil is obtained by adding ethylene oxide to hydrogenated castor oil, and usually contains 5 to 80 mol of ethylene oxide. Among them, those to which 20 to 60 mol of ethylene oxide is added are particularly preferable. As the polyoxyethylene alkyl ether, those represented by the following formula (1) are preferable.
【0017】 R−O−(EO)nH (1) (但し、Rは炭素数16〜22のアルキル基、nは2〜
5、EOは酸化エチレンを表わす。)R—O— (EO) n H (1) (where R is an alkyl group having 16 to 22 carbon atoms, and n is 2 to 2)
5, EO represents ethylene oxide. )
【0018】なお、上記式(1)においてRとしては、
炭素数16〜20、n(酸化エチレンの付加モル数)は
3〜5のものがより好ましい。In the above formula (1), R is
Those having 16 to 20 carbon atoms and n (the number of added moles of ethylene oxide) of 3 to 5 are more preferable.
【0019】また、本発明の食前使用口腔用組成物は、
メントール、カルボン、ペパーミント油、スペアミント
油、サリチル酸メチルの配合量の合計が組成物全体の
0.5%以下、好ましくは0.1%以下、更に好ましく
は0.01%以下である。The oral composition for pre-meal use of the present invention comprises:
Menthol, carvone, peppermint oil, spearmint oil, the total amount of methyl salicylate 0.5% or less of the total composition, preferably 0.1% or less, further preferably 0.01% or less.
【0020】本発明の食前使用口腔用組成物は、練歯
磨、液状歯磨等の歯磨類、洗口剤などの適宜な種類、形
態に調製される。この場合、調製される口腔用組成物の
種類、形態に応じた公知の成分を配合することができ
る。The oral composition for pre-meal use of the present invention is prepared in an appropriate type and form such as dentifrice such as toothpaste and liquid dentifrice, mouthwash and the like. In this case, known components can be blended according to the type and form of the oral composition to be prepared.
【0021】例えば、歯磨類の場合は、研磨剤、粘稠
剤、粘結剤、甘味剤、防腐剤、色素等を配合でき、これ
ら成分と水とを混合し、製造できる。For example, in the case of dentifrices, abrasives, thickeners, binders, sweeteners, preservatives, pigments and the like can be blended, and these components can be mixed with water to produce.
【0022】研磨剤としては、シリカゲル、沈降性シリ
カ、火成性シリカ、アルミノシリケート、ジルコノシリ
ケート等のシリカ系研磨剤、第2リン酸カルシウム2水
和物、第2リン酸カルシウム無水和物、ピロリン酸カル
シウム、水酸化アルミニウム、アルミナ、2酸化チタ
ン、結晶性ジルコニウムシリケート、ポリメチルメタア
クリレート、不溶性メタリン酸カルシウム、軽質炭酸カ
ルシウム、重質炭酸カルシウム、炭酸マグネシウム、第
3リン酸マグネシウム、ゼオライト、ケイ酸ジルコニウ
ム、第3リン酸カルシウム、ハイドロキシアパタイト、
フルオロアパタイト、カルシウム欠損アパタイト、第3
リン酸カルシウム、第4リン酸カルシウム、第8リン酸
カルシウム、合成樹脂系研磨剤などが挙げられる。Examples of the abrasive include silica-based abrasives such as silica gel, precipitated silica, igneous silica, aluminosilicate and zirconosilicate, dibasic calcium phosphate dihydrate, dibasic calcium phosphate anhydrate, calcium pyrophosphate, Aluminum hydroxide, alumina, titanium dioxide, crystalline zirconium silicate, polymethyl methacrylate, insoluble calcium metaphosphate, light calcium carbonate, heavy calcium carbonate, magnesium carbonate, tribasic magnesium phosphate, zeolite, zirconium silicate, tertiary Calcium phosphate, hydroxyapatite,
Fluorapatite, calcium-deficient apatite, tertiary
Calcium phosphate, quaternary calcium phosphate, octacalcium phosphate, synthetic resin-based abrasives and the like can be mentioned.
【0023】粘稠剤としては、グリセリン、ソルビッ
ト、プロピレングリコール、分子量200〜6000の
ポリエチレングリコール、エチレングリコール、還元で
んぷん糖化物等の多価アルコール等の1種又は2種以上
が使用できる。As the thickener, one or two or more of glycerin, sorbit, propylene glycol, polyethylene glycol having a molecular weight of 200 to 6,000, polyhydric alcohol such as reduced starch saccharified product, and the like can be used.
【0024】粘結剤としては、キサンタンガム、アルギ
ン酸ナトリウム、アルギン酸プロピレングリコールエス
テル、カルボキシメチルセルロース、ポリビニルアルコ
ール、ヒドロキシエチルセルロース、カラギーナン、カ
ーボポール、グアガム、ゼラチン、アビセル、それにモ
ンモリロナイト、カオリン、ベントナイト等の無機粘結
剤等が挙げられる。Examples of the binder include xanthan gum, sodium alginate, propylene glycol alginate, carboxymethylcellulose, polyvinyl alcohol, hydroxyethylcellulose, carrageenan, carbopol, guar gum, gelatin, Avicel, and inorganic binders such as montmorillonite, kaolin and bentonite. Agents and the like.
【0025】甘味剤としては、サッカリンナトリウム、
アスパラテーム、ステビオサイド、ステビアエキス、パ
ラメトキシシンナミックアルデヒド、ネオヘスペリジル
ジヒドロカルコン、ペリラルチン等、防腐剤としては、
ブチルパラベン、エチルパラベン等のパラベン類、パラ
オキシ安息香酸エステル、安息香酸ナトリウム等が挙げ
られる。As sweeteners, sodium saccharin,
As preservatives such as aspartame, stevioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidyl dihydrochalcone, perillartin,
Examples thereof include parabens such as butylparaben and ethylparaben, paraoxybenzoate, sodium benzoate and the like.
【0026】なお、本発明の食前使用口腔用組成物に
は、各種薬効成分を配合することは差支えないが、味の
点などで特に配合する必要はない。The oral composition for pre-meal use of the present invention may contain various medicinal ingredients, but it is not necessary to particularly mix them in terms of taste and the like.
【0027】更に、香料は上述したようにメントール、
カルボン、ペパーミント油、スペアミント油、サリチル
酸メチルの合計配合量を組成物全体の0.5%以下とす
る限り、適宜な香料、例えばアネトールなどを配合する
ことができる。Further, the fragrance is menthol as described above,
As long as the total amount of carboxyl, peppermint oil, spearmint oil, and methyl salicylate is not more than 0.5% of the total composition, an appropriate flavor such as anethole can be added.
【0028】本発明の食前使用口腔用組成物は、その種
類、形態による通常の方法で食事前に適用され、次いで
食事後、通常の歯磨、洗口剤等の口腔用組成物を用いて
口内清掃を行うことが好ましいが、本発明の食前使用口
腔用組成物を使用することで、食後適用の口腔用組成物
を使用した際にその食後適用の口腔用組成物の効果を妨
害することはなく、むしろ、抗菌剤等の薬効成分を配合
した口腔用組成物の効果をさらに高めることが可能であ
る。The oral composition for pre-meal use according to the present invention is applied before meals by a usual method according to its type and form, and then, after meals, the oral composition such as a normal toothpaste and mouthwash is used. Although it is preferable to perform cleaning, by using the oral composition for pre-meal use of the present invention, when the oral composition for post-meal application is used, it is difficult to hinder the effect of the oral composition for post-meal application. Rather, it is possible to further enhance the effect of the oral composition containing a medicinal ingredient such as an antibacterial agent.
【0029】従って、本発明の食前使用口腔用組成物
は、抗菌剤等の薬効成分を含有し、より好ましくは更に
薬効成分口腔内滞留化剤を配合した食後使用の口腔用組
成物と併用することが好ましい。Accordingly, the pre-meal oral composition of the present invention contains a medicinal ingredient such as an antibacterial agent, and is more preferably used in combination with a post-meal oral composition further containing a medicinal ingredient-oral retention agent. Is preferred.
【0030】ここで、食前使用口腔用組成物と併用する
食後使用の口腔用組成物に配合する抗菌剤等の薬効成分
としては、トリクロサン等のハロゲン化ジフェニルエー
テル、クエン酸亜鉛、塩化亜鉛等の亜鉛化合物、銅化合
物、イソプロピルメチルフェノール、チモール、カルバ
クロール、塩化セチルピリジニウム、塩化ベンゼトニウ
ム、塩化ベンザルコニウム、塩化デカリニウム、塩酸ア
ルキルジアミノエチルグリシン、塩化クロルヘキシジン
の塩酸及びグルコン酸塩、サンギナリン抽出物、オウバ
クエキス、ヒノキチオール、フッ化スズ、口腔細菌を抗
原とする免疫抗体、デキストラナーゼ、ムタナーゼ等の
歯垢に作用する酵素類等の口腔内細菌に対して抗菌効果
を有する成分を挙げることができる。また、薬効成分口
腔内滞留化剤としては、メトキシエチレン/マレイン酸
共重合体、カチオン性ポリマー、アルギン酸ナトリウム
等が例示される。The medicinal component such as an antibacterial agent to be added to the oral composition to be used after eating in combination with the oral composition to be used before eating includes halogenated diphenyl ethers such as triclosan, zinc citrate and zinc chloride such as zinc chloride. Compounds, copper compounds, isopropylmethylphenol, thymol, carvacrol, cetylpyridinium chloride, benzethonium chloride, benzalkonium chloride, decalinium chloride, alkyldiaminoethylglycine hydrochloride, hydrochloric acid and gluconate of chlorhexidine chloride, sanguinarine extract, oubaku extract And hinokitiol, tin fluoride, immune antibodies having oral bacteria as antigens, and components having an antibacterial effect on oral bacteria such as enzymes that act on plaque such as dextranase and mutanase. Examples of the medicinal ingredient oral retention agent include methoxyethylene / maleic acid copolymer, cationic polymer, sodium alginate and the like.
【0031】なお、この食後に適用される口腔用組成物
におけるその他の成分は、公知の通常の歯磨、洗口剤等
の口腔用組成物の成分組成とすることができる。従っ
て、これに用いる界面活性剤の種類及び配合量、香料の
種類、配合量は特に限定されず、公知の通常のものを常
用量で用いることができる。The other components of the oral composition to be applied after eating can be the component compositions of well-known ordinary oral compositions such as dentifrices and mouthwashes. Therefore, the type and amount of the surfactant and the type and amount of the fragrance are not particularly limited, and known ordinary ones can be used at ordinary doses.
【0032】[0032]
【発明の効果】本発明の食前使用口腔用組成物は、食前
の唾液中の口腔疾患原因細菌数を大幅に減少させ、直後
の食事の味覚に影響がなく、特に抗菌剤等の薬効成分を
配合した食後使用の口腔用組成物と併用することによっ
て、唾液中の口腔疾患の原因細菌数を低レベルに維持す
ることができる。EFFECTS OF THE INVENTION The oral composition of the present invention for use before meals significantly reduces the number of bacteria causing oral diseases in saliva before meals, has no effect on the taste of meal immediately after meals, and has a medicinal component such as an antibacterial agent. When used in combination with the formulated oral composition for postprandial use, the number of bacteria causing oral diseases in saliva can be maintained at a low level.
【0033】[0033]
【実施例】以下、本発明を実施例と比較例によって説明
するが、本発明はこれによって限定されるものではな
い。なお、下記の例で%は質量百分率を示す。The present invention will be described below with reference to examples and comparative examples, but the present invention is not limited to these examples. In the following examples,% indicates mass percentage.
【0034】また、下記の例で、香料A、Bはそれぞれ
下記の組成である。香料A アップルエッセンシャルベース香料 60% メントール 30 アネトール 10 計 100%香料B メントール 30% ペパーミント油 50 アネトール 2 シネオール 1 リモネン 1 レモン油 0.5 カシア油 0.5 クローブ油 0.5 エタノール 残 計 100%In the following examples, the fragrances A and B have the following compositions, respectively. Perfume A Apple Essential Base Fragrance 60% Menthol 30 Anethol 10 Total 100% Fragrance B Menthol 30% Peppermint Oil 50 Anethole 2 Cineol 1 Limonene 1 Lemon Oil 0.5 Cassia Oil 0.5 Clove Oil 0.5 Ethanol 100%
【0035】[実施例1〜4、比較例1〜6、参考例
1]下記組成の食前使用口腔用組成物(歯磨)を調製し
た。 無水ケイ酸 20% 70%ソルビット液 45 カルボキシメチルセルロースナトリウム 1 プロピレングリコール 2.5 エチルパラベン 0.1 サッカリンナトリウム 0.1 香料A又はB 1 ラウリル硫酸ナトリウム(SDS) 表1に示す量 表1に示す非イオン界面活性剤 表1に示す量 精製水 残 計 100% 上記食前使用口腔用組成物を使用し、下記の手順で実験
を行った(被験者5名)。Examples 1 to 4, Comparative Examples 1 to 6, Reference Example 1 An oral composition (toothpaste) having the following composition was prepared. Silicic anhydride 20% 70% sorbite solution 45 Carboxymethylcellulose sodium 1 Propylene glycol 2.5 Ethylparaben 0.1 Saccharin sodium 0.1 Fragrance A or B 1 Sodium lauryl sulfate (SDS) Amount shown in Table 1 Non-ionic shown in Table 1 Surfactant The amount of purified water shown in Table 1 balance 100% An experiment was conducted by the following procedure using the above-mentioned composition for oral use before meals (5 subjects).
【0036】各被験者より唾液約1mLを採取した
(唾液A)。 上記食前使用口腔用組成物を各被験者の通常の使用法
にて使用させ、3分間の歯磨きを行った。 唾液約1mLを採取した(唾液B)。 食事 下記の食後使用口腔用組成物No.1(洗口液)又は
No.2(歯磨)を各被験者の通常の使用法にて使用さ
せ、30秒間の洗口又は3分間の歯磨を行った。 3時間後、唾液約1mLを採取した(唾液C)。About 1 mL of saliva was collected from each subject (saliva A). The oral composition for pre-meal use was used in the usual manner for each subject, and the teeth were brushed for 3 minutes. About 1 mL of saliva was collected (saliva B). Meal The following oral composition No. No. No. 1 (mouthwash) or No. 1 2 (toothpaste) was used according to the usual use of each subject, and the mouth was washed for 30 seconds or brushed for 3 minutes. Three hours later, about 1 mL of saliva was collected (saliva C).
【0037】食後使用口腔用組成物No.1(洗口液) 99.5%エタノール 10% 85%グリセリン 15 香料B 0.3 サッカリンナトリウム 0.1 安息香酸ナトリウム 0.2 ポリオキシエチレン硬化ヒマシ油(E.O.60) 1 クエン酸 0.1 クエン酸ナトリウム 0.3 塩化セチルピリジニウム 0.05 カチオン化セルロース 0.1 精製水 残 計 100% Composition for oral cavity used after meal No. 1 (mouthwashes) 99.5% Ethanol 10% 85% Glycerin 15 Perfume B 0.3 Sodium saccharin 0.1 Sodium benzoate 0.2 polyoxyethylene hydrogenated castor oil (E.O.60) 1 Citric acid 0. 1 Sodium citrate 0.3 Cetylpyridinium chloride 0.05 Cationized cellulose 0.1 Purified water Balance 100%
【0038】食後使用口腔用組成物No.2(歯磨) 無水ケイ酸 20% 70%ソルビット液 45 カルボキシメチルセルロースナトリウム 1 プロピレングリコール 2.5 香料B 1 キサンタンガム 0.5 アルギン酸ナトリウム 0.5 ブチルパラベン 0.1 サッカリンナトリウム 0.2 トリクロサン 0.3 精製水 残 計 100% Composition for oral cavity after use after eating 2 (Toothpaste) Silicic anhydride 20% 70% Sorbite solution 45 Sodium carboxymethylcellulose 1 Propylene glycol 2.5 Perfume B 1 Xanthan gum 0.5 Sodium alginate 0.5 Butylparaben 0.1 Saccharin sodium 0.2 Triclosan 0.3 Purified water 100% remaining
【0039】以上の実験により、食前使用口腔用組成物
を使用した前後のう蝕原因菌数の減少度及び味の変化に
ついて下記方法により評価した。結果を表1に示す。From the above experiments, the following methods were used to evaluate the degree of reduction in the number of cariogenic bacteria and the change in taste before and after using the oral composition before meals. Table 1 shows the results.
【0040】使用前後平均う蝕原因菌数減少度 使用前後平均う蝕原因菌数減少度は、各被験者の使用前
後う蝕原因菌数減少度の平均値であり、2以上を〇とし
た。 使用前後う蝕原因菌数減少度=Log(唾液菌数A)−
Log(使用後菌数B) 食後3時間後う蝕原因菌数減少度=Log(唾液菌数
A)−Log(使用後菌数C) Average decrease in the number of cariogenic bacteria before and after use The average decrease in the number of cariogenic bacteria before and after use is the average value of the decrease in the number of cariogenic bacteria before and after use of each subject. Degree of decrease in the number of cariogenic bacteria before and after use = Log (salivary bacteria count A)-
Log (Bacterial count B after use) Degree of decrease in the number of cariogenic bacteria 3 hours after eating = Log (Bacterial count A) -Log (Bacterial count C after use)
【0041】唾液中う蝕原因菌数の測定 採取した唾液を0.85%の生理食塩水で10〜105
倍までの5種類の希釈液を作製する。希釈倍率の異なる
5種類の液を各々1秒間、超音波処理を2回行い、MS
B寒天培地(Mitis−salivarius 培地
に20%のスクロースと0.2単位/mLのバシトラシ
ンを添加したもの)に50μLずつまき、37℃、2日
間嫌気培養した後、コロニー数を測定する。 Measurement of the number of causative bacteria in saliva The collected saliva was treated with 0.85% physiological saline for 10 to 10 5.
Make up to five dilutions of up to five times. The ultrasonic treatment was performed twice for 1 second each for 5 kinds of liquids having different dilution ratios, and MS
50 μL is spread on a B agar medium (Mit-salivarius medium supplemented with 20% sucrose and 0.2 unit / mL bacitracin), and anaerobically cultured at 37 ° C. for 2 days, followed by counting the number of colonies.
【0042】味の変化 食前使用口腔用組成物の使用前後に100%オレンジジ
ュースを試飲し、使用前の味と比較して使用後の味の変
化について、下記の4段階の項目で評価し、5名の平均
値を評点し、3点以上を○とした。 4 変わらない 3 やや味が異なる(限度内) 2 味が異なる 1 非常に味が異なる Taste Change Before and after use of the oral composition, a 100% orange juice was tasted, and the taste change after use compared with the taste before use was evaluated according to the following four grades. The average value of five persons was rated, and three points or more were evaluated as ○. 4 No change 3 Slightly different taste (within limit) 2 Different taste 1 Very different taste
【0043】[0043]
【表1】 (注)非イオン界面活性剤種 C:ポリオキシエチレンステアリルエーテル(E.O.
5) D:ポリエチレン硬化ヒマシ油(E.O.60) E:ショ糖パルミチン酸エステル(モノエステル70
%)[Table 1] (Note) Nonionic surfactant C: Polyoxyethylene stearyl ether (E.O.
5) D: Polyethylene hardened castor oil (EO60) E: Sucrose palmitate (monoester 70)
%)
【0044】 [実施例5]食前使用洗口液 99.5%エタノール 10% 85%グリセリン 15 香料A 0.5 サッカリンナトリウム 0.1 安息香酸ナトリウム 0.1 ラウリル硫酸ナトリウム 1.1 ノニオン界面活性剤 0.5 精製水 残 計 100%Example 5 Pre-meal mouthwash 99.5% Ethanol 10% 85% Glycerin 15 Fragrance A 0.5 Saccharin sodium 0.1 Sodium benzoate 0.1 Sodium lauryl sulfate 1.1 Nonionic surfactant 0 .5 purified water balance 100%
【0045】 [実施例6]食前使用練歯磨 シリカ 20% 70%ソルビット液 50 プロピレングリコール 5 キサンタンガム 0.5 イオタカラギーナン 0.5 パラオキシ安息香酸メチル 0.1 サッカリンナトリウム 0.2 フッ化ナトリウム 0.2 ラウリル硫酸ナトリウム 1.2 ポリオキシエチレン硬化ヒマシ油(E.O.20) 0.6 香料A 1 精製水 残 計 100%Example 6 Toothpaste Silica 20% 70% Sorbit Solution 50 Propylene Glycol 5 Xanthan Gum 0.5 Iota Carrageenan 0.5 Iota Carrageenan 0.5 Methyl Paraoxybenzoate 0.1 Saccharin Sodium 0.2 Sodium Fluoride 0.2 Lauryl Sodium sulfate 1.2 Polyoxyethylene hydrogenated castor oil (EO20) 0.6 Perfume A 1 Purified water Balance 100%
【0046】 [実施例7]食前使用練歯磨 リン酸水素カルシウム 50% 70%ソルビット液 20 グリセリン 5 プロピレングリコール 5 カルボキシメチルセルロースナトリウム 1 パラオキシ安息香酸メチル 0.1 サッカリンナトリウム 0.2 モノフルオロリン酸ナトリウム 0.7 ラウリル硫酸ナトリウム 1.8 ポリオキシエチレンステアリルエーテル(E.O.5) 0.9 香料A 1 精製水 残 計 100%Example 7 Toothpaste Toothpaste Calcium Hydrogen Phosphate 50% 70% Sorbitol Solution 20 Glycerin 5 Propylene Glycol 5 Sodium Carboxymethyl Cellulose 1 Methyl Paraoxybenzoate 0.1 Sodium Saccharin 0.2 Sodium Monofluorophosphate 0. 7 Sodium lauryl sulfate 1.8 Polyoxyethylene stearyl ether (EO5) 0.9 Perfume A 1 Purified water Balance 100%
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 31/765 A61K 31/765 A61P 1/02 A61P 1/02 Fターム(参考) 4C083 AA121 AB172 AB282 AC102 AC122 AC132 AC181 AC182 AC302 AC312 AC431 AC432 AC482 AC692 AC782 AC812 AC862 AD132 AD201 AD202 AD272 AD302 AD352 AD531 BB04 BB05 CC41 DD22 DD23 DD27 EE33 4C086 AA01 EA05 FA02 MA03 MA05 MA57 NA05 NA10 ZA67 ZB35 4C206 AA01 FA51 JA06 MA03 MA05 MA77 NA05 NA10 ZA67 ZB35──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A61K 31/765 A61K 31/765 A61P 1/02 A61P 1/02 F term (Reference) 4C083 AA121 AB172 AB282 AC102 AC122 AC132 AC181 AC182 AC302 AC312 AC431 AC432 AC482 AC692 AC782 AC812 AC862 AD132 AD201 AD202 AD272 AD302 AD352 AD531 BB04 BB05 CC41 DD22 DD23 DD27 EE33 4C086 AA01 EA05 FA02 MA03 MA05 MA57 NA05 NA10 ZA67 ZB35 4C206 AA01 MA51 MA05 MA06
Claims (1)
使用口腔用組成物であって、アニオン界面活性剤を0.
1〜3質量%含有すると共に、ショ糖脂肪酸エステル、
ポリオキシエチレン硬化ヒマシ油及びポリオキシエチレ
ンアルキルエーテルから選ばれる非イオン界面活性剤を
上記アニオン界面活性剤量の1/5〜2/3含有し、か
つメントール、カルボン、ペパーミント油、スペアミン
ト油及びサリチル酸メチルの配合量の合計が0.5質量
%以下であることを特徴とする食前使用口腔用組成物。1. An oral composition for use before meals used in combination with an oral composition for use after meals, wherein an anionic surfactant is added to the oral composition.
Containing 1 to 3% by mass, sucrose fatty acid ester,
A nonionic surfactant selected from polyoxyethylene hydrogenated castor oil and polyoxyethylene alkyl ether is contained in an amount of 1/5 to 2/3 of the amount of the above anionic surfactant, and menthol, carvone, peppermint oil, spearmint oil and salicylic acid are contained. A pre-meal oral composition, wherein the total amount of methyl is 0.5% by mass or less.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001092208A JP2002284691A (en) | 2001-03-28 | 2001-03-28 | Composition for oral cavity taken before meal |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001092208A JP2002284691A (en) | 2001-03-28 | 2001-03-28 | Composition for oral cavity taken before meal |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002284691A true JP2002284691A (en) | 2002-10-03 |
Family
ID=18946714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001092208A Pending JP2002284691A (en) | 2001-03-28 | 2001-03-28 | Composition for oral cavity taken before meal |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2002284691A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102940696A (en) * | 2012-11-08 | 2013-02-27 | 辛晓林 | Drug for treating toothache |
-
2001
- 2001-03-28 JP JP2001092208A patent/JP2002284691A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102940696A (en) * | 2012-11-08 | 2013-02-27 | 辛晓林 | Drug for treating toothache |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0548246A1 (en) | DEVICE AND METHOD FOR STEREOSCOPIC VIEWING OF DIAS AND PRINTING. | |
EP0854702B1 (en) | Antimicrobial compositions containing a c 3-c 6 alcohol | |
JP2002521416A (en) | Anti-inflammatory dental care preparation | |
WO2003103618A1 (en) | Compositions for oral cavity | |
JP2008143825A (en) | Tooth paste composition | |
JP5310556B2 (en) | Oral composition and method for improving astringency of oral composition | |
US6447758B1 (en) | Cationic antibacterial dentifrice exhibiting superior foaming properties | |
JP2003501454A (en) | Synergistic and antibacterial combination | |
JP2002179541A (en) | Composition for oral cavity containing cationic disinfectant | |
JPH1121219A (en) | Composition for oral cavity | |
JP5084075B2 (en) | Oral cleaning composition | |
CA2297454A1 (en) | Oral and dental hygiene products for sensitive teeth | |
WO1996015770A1 (en) | Antimicrobial oral compositions | |
JP2015117215A (en) | Dentifrice composition | |
CA2754213C (en) | Desensitizing dentifrice exhibiting dental tissue antibacterial agent uptake | |
JP3189549B2 (en) | Oral composition | |
JP2002255773A (en) | Composition for oral cavity | |
JP2002284691A (en) | Composition for oral cavity taken before meal | |
JP2000319153A (en) | Composition for oral cavity | |
JPH1129454A (en) | Composition for oral cavity | |
JP2007161613A (en) | Dentifrice composition | |
JPH10330230A (en) | Composition for oral cavity and reinforcement of antibacterial property | |
JP2001172145A (en) | Composition for oral cavity | |
JPH09235215A (en) | Composition for oral cavity | |
JP2004018521A (en) | Formulation for oral cavity |